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Epidermal infiltration by neoplastic CD4F T cells is a
characteristic histologic feature of early stage mycosis
fungoides, the most common type of cutaneous T cell
lymphoma (CTCL). The mechanisms involved in epider-
motropism are unknown. It has been suggested that the
CXC chemokines IL-8 and interferon-g inducible protein
10 (IP-10) may play a role, but evidence that these
chemokines are produced within the epidermis in epider-
motropic CTCL is lacking. In this study skin biopsies
from 17 CTCL patients, including 12 mycosis fungoides,
four pleomorphic CTCL, and one CD8F CTCL, were
investigated for epidermal IL-8 and IP-10 mRNA expres-
sion by RNA in situ hybridization. In addition, the
expression of monokine induced by g-interferon (Mig)
mRNA, a CXC chemokine closely related to IP-10, was
studied as well. The expression of IL-8 receptors A and
B (CXCR1 and CXCR2, respectively) was investigated
Mycosis fungoides (MF) is the most common type ofcutaneous T cell lymphoma (CTCL). Epidermalinfiltration by atypical CD31CD41CD8– T cellswith cerebriform and hyperchromatic nuclei (epid-ermotropism) is a characteristic feature in the early
patch and plaque stages of this disease. With progression to tumor
stage MF the affinity of the neoplastic T cells for the epidermis may
get lost, which is often associated with a more unfavorable prognosis
(Edelson, 1980). Similarly, large pleomorphic CTCL (CD30 negative),
which may develop from pre-existing MF or may develop de novo in
the skin, are often nonepidermotropic and have a poor prognosis
(Beljaards et al, 1994).
Recent studies have started to evaluate the mechanisms underlying
the affinity of these neoplastic T cells for the epidermis. These studies
have focused above all on the potential role of chemokines, a
recently defined superfamily of cytokines with chemotactic and immune
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by immunohistochemistry. The results were correlated
with the number and phenotype of epidermotropic T
cells. Epidermal expression of IP-10 and Mig mRNA was
detected in 10 of 11 and seven of 11 epidermotropic
CTCL, respectively, but not in five nonepidermotropic
CTCL biopsies or normal human skin. Epidermal IP-10
and Mig mRNA expression correlated with epidermal
infiltration of CD4F T cells, but not of CD8F T cells.
IL-8 mRNA was demonstrated in the epidermis of only
two of 15 CTCL biopsies, and was associated, in both
cases, with accumulation of neutrophils. Consistently,
immunostaining of the (intraepidermal) T cells with
antibodies against CXCR1 and CXCR2 was not observed.
In conclusion, the results of this study indicate that IP-
10, and to a lesser extent Mig, but not IL-8 is involved
in the preferential infiltration of neoplastic CD4F T
cells in CTCL. Key words: chemokine/CTCL/RNA in situ
hybridization. J Invest Dermatol 111:222–226, 1998
response modulating properties. Chemokines can be divided into four
subfamilies, C, CC, CXC, and CXXXC chemokines, depending on
the position of the characteristic cysteine residues within their amino
terminal (Miller and Krangel, 1992; Baggiolini et al, 1994; Murphy,
1994; Bazan et al, 1997; Wells and Peitsch, 1997). The CC chemokines
(e.g., RANTES and the MCP) mainly affect monocytes and T cells
(Oppenheim et al, 1991; Miller and Krangel, 1992). The group of
CXC chemokines can be subdivided into a group containing the ELR
motif preceding the CXC sequence (e.g., IL-8 and GRO) mainly
affecting neutrophils (Oppenheim et al, 1991), and a group which lacks
this ELR motif [e.g., interferon-γ inducible protein 10 (IP-10) and
monokine induced by γ-interferon (Mig)], now recognized to have
activity towards activated T cells (Taub et al, 1993b; Farber, 1997). IP-
10 and Mig are closely related chemokines, which share at least one
receptor termed CXCR3 (Loetscher et al, 1996). Both chemokines
are chemotactic for stimulated T cells and natural killer cells, inhibit
angiogenesis, and exert anti-tumor effects (Farber, 1997).
Previous, mainly immunohistochemical, studies in skin biopsies of
MF suggested that both IL-8 (Hansen et al, 1991; McLean Wismer
et al, 1994) and IP-10 (Sarris et al, 1995) play an important role in the
preferential migration of neoplastic T cells into the epidermis. Expres-
sion of Mig mRNA or protein in CTCL has not been studied thus
far; however, immunostaining by anti-chemokine antibodies on skin
tissue sections is often difficult to interpret, and does not always
reflect the presence of biologically active forms of these chemokines
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(Sticherling et al, 1989). In addition, more recent studies have questioned
the chemotactic properties of IL-8 for T cells (Taub et al, 1993a; Carr
et al, 1994; Roth et al, 1995).
Because we were interested in whether these chemokines are
produced within the epidermis itself, in this study biopsies from
patients with various stages of MF and large pleomorphic CTCL were
investigated for the expression of IL-8 and IP-10, as well as Mig
mRNA by RNA in situ hybridization (RISH). In addition, we
examined IL-8 receptor A and B (CXCR1 and CXCR2) expression
by immunohistochemistry. The results were correlated with the number
and phenotype of the epidermotropic T cells.
MATERIALS AND METHODS
Patients Skin biopsies were obtained from untreated skin lesions of 17 CTCL
patients, including eight patients with patch/plaque stage MF, four patients
with tumor stage MF, four patients with a large pleomorphic T cell lymphoma,
and one patient with a strongly epidermotropic CD81 CTCL. In all cases the
diagnosis was based on a combination of clinical, histologic, and immunopheno-
typical data, as described previously (Willemze et al, 1997). The neoplastic T
cells had a CD31CD41CD8– T cell phenotype in all cases, except for the
single patient with a CD81 CTCL. Because IL-8 mRNA expression in
psoriatic epidermis has been well established, skin biopsies from untreated
psoriatic lesions (n 5 4), uninvolved skin of these psoriatic patients (n 5 4), in
addition to normal human skin of healthy volunteers (n 5 10), were included
as control groups.
Immunohistochemical analysis Five micrometer frozen tissue sections
were fixed in acetone for 10 min at room temperature, and subsequently
incubated with appropriately diluted first antibody, biotinylated goat anti-mouse
Ig antibody (DAKO, Copenhagen, Denmark) and HRP-labeled streptavidin
(DAKO). HRP-enzyme activity was revealed using AEC/H2O2 as substrate
solution and the sections were counterstained with Mayers hematoxylin and
coverslipped with Aquaperm. The first antibodies used are against CD3 and
CD4 (clones BB11 and BF5, respectively, Biosource International, Camarillo,
CA), CD8 (clone BC8, Dr. J Wijdenes, Besanc¸on, France), CD54 (clone
MEM111, Monosan, Uden, The Netherlands), CXCR1 (clone 5 A12, Leuko-
site, Cambridge, MA), CXCR2 (clone 10H2, Genentech, San Francisco, CA),
and Neutrophil Elastase (clone NP57, DAKO).
In situ hybridization
Preparation of 35S labeled RNA probes To obtain IP-10 and Mig encoding
cDNA fragment, reverse transcription of oligo(dt) primed total RNA (1 µg)
isolated from IFN-γ stimulated primary cultured keratinocytes (Boorsma et al,
1994) was performed in 20 µl for 1 h at 42°C using 200 U Superscript II
RT according to the manufacturer’s instructions (Gibco/BRL, Breda, The
Netherlands). Subsequently, two primers (25 pmol each) corresponding to IP-
10 mRNA or Mig mRNA (see Table I) were used in a 50 µl polymerase
chain reaction (PCR) containing 0.5 U Taq-polymerase (Boehringer Mannheim,
Almere, The Netherlands), 0.2 mM of each dNTP and 5 µl first strand cDNA,
in 10 mM Tris-HCl (pH 8.3), 50 mM KCl; 1.5 mM MgCl2 [32 cycles of 30@
94°C, 19 55°C, and 19 72°C in a thermal cycler (MJ Research, Watertown,
MA)]. A single PCR product of the expected size (189 bp for IP-10 and 324
bp for Mig) was generated, polished (PCR product polishing kit; Stratagene,
La Jolla, CA), and cloned in EcoRV digested pZErO (Invitrogen, Leek, The
Netherlands). Resulting plasmid DNA were sequenced using the dideoxy chain
termination method (Sanger et al, 1977) in order to determine the nature and
orientation of the inserts. pZErO plasmid DNA harboring the IP-10 or Mig
encoding cDNA fragments in either orientation were linearized with BamHI
and 35S labeled sense (control) and anti-sense RNA probes were obtained by
in vitro transcription with T7 RNA polymerase using the Riboprobe system
according to the manufacturer’s instructions (Promega, Leiden, The
Netherlands).
To obtain a cDNA fragment encoding IL-8, 25 pmol of two primers
corresponding to IL-8 mRNA with a RNA polymerase promotor sequence
engineered in the 59 end (T7 for the sense and T3 for the anti-sense primer)
were used in a 100 µl PCR using 1 ng of clone 3–10C (Schmid and Weissmann,
1987) as a template under the conditions as described above. The PCR
generated IL-8 encoding cDNA fragment flanked by T3 and T7 RNA
polymerase promotors was agarose gel purified in combination with Qiaex
spinbind columns (Diagen, Duesseldorf, Germany) and used to synthesize anti-
sense (T3) and sense (T7) RNA probes with the Riboprobe system.
After 2 h of transcription, DNA templates were degraded with RQ1 RNase-
Free DNase I (10 U; Promega) and the labeled riboprobes were recovered by
ethanol precipitation using 20 µg yeast t-RNA as carrier, subsequently dissolved
in formamide, and counted. The specific activity of the probes was on average
between 5 3 108 and 1 3 109 dpm RNA per µg.
Hybridization procedure Frozen tissue sections (10 µm) were fixed with paraform-
aldehyde (4%), acetylated with acetic anhydride in 0.1 M triethanolamine,
dehydrated in graded alcohol, treated with chloroform, and air dried. Thereafter
sections were overlaid with 100 µl hybridization buffer [50% formamide,
43sodium citrate/chloride buffer (SSC), 1 3 Denhardt, 100 mM dithiothreitol,
250 µg t-RNA per ml, 100 µg denatured heterologous herring sperm DNA
per ml, and 1 µg RNA per ml transcribed from BamHI linearized pZErO
without insert] containing 1–2 3 104 cpm probe per µl. Sections were mounted
with cover slips and hybridized for 16–18 h at 47–50°C in a humidified
chamber. After hybridization, nonhybridized probes were removed using high
stringency washes with 50% formamide/23SSC at 45°C (twice for 20 min),
rinsing in 23SSC, and followed by treatment with RNase A (100 mg per ml)
in 23SSC at 37°C (30 min). Next, slides were washed with 50% formamide/
23SSC at 45°C (3320 min) and finally two washes with 23SSC at room
temperature. For autoradiography, dried slides were dipped in Ilford K5 solution,
exposed for 1–5 wk, developed using Kodak D19, and counterstained with
hematoxylin.
RESULTS
Immunocytochemistry Immunostaining using monoclonal anti-
bodies against CD3, CD4, and CD8 was used to assess the degree and
nature of the epidermotropic T cells. In skin biopsies from patients
with MF and pleomorphic CTCL, six of 16 cases (nos 1–6) showed
moderate to extensive infiltration of the basal and suprabasal layers of
the epidermis, five cases (nos 7–11) showed only sparse, often focal
infiltration, whereas in five cases (nos 12–16) epidermotropism was
completely absent (Table II). The large majority of the epidermotropic
T cells were neoplastic CD41 T cells, whereas CD81 T cells were
generally few or absent. The single patient with a CD81 CTCL (no.
17) showed massive epidermal infiltration by neoplastic CD81 T cells,
whereas there was only focal infiltration by reactive CD41 T cells.
CD54, which, as IP-10, is expressed by keratinocytes upon activation
with IFN-γ (Dustin et al, 1988), was expressed by epidermal ker-
atinocytes in 10 of 17 biopsies. There was a strong correlation between
CD54 expression and the presence of epidermotropic T cells.
CXCR2 expression was not detected in any of the CTCL specimens
tested and CXCR1 expression was only found on dendritic cells in
the epidermis or dermis, and in two cases (nos 2 and 6) on epidermal
neutrophils. Thus, the neoplastic T cells expressed neither CXCR1
nor CXCR2. In control specimens of lesional psoriatic skin, CXCR2
staining was observed on the suprabasal keratinocytes, whereas CXCR1
staining was found on dendritic cells and neutrophils. In the epidermis
of normal skin of psoriatic patients and healthy controls, staining for
CXCR2 was completely negative, whereas CXCR1 was only faintly
expressed by dendritic cells.
In situ hybridization IP-10 mRNA expression was found in the
epidermis, mainly in the basal and suprabasal layers of 11 of 17 biopsies
(Table II). IP-10 mRNA expression showed a patchy rather than
uniform pattern (Fig 1). In the group of MF and pleomorphic CTCL,
epidermal IP-10 mRNA expression was found in six of six biopsies
showing moderate to extensive epidermotropism (nos 1–6) and in
three of five biopsies (nos 9–11) showing only focal epidermal
infiltration by neoplastic CD41 T cells, but was not observed in the
five nonepidermotropic CTCL (nos 12–16). Mig mRNA expression
was found in seven of these 11 epidermotropic MF/pleomorphic
CTCL, but not in any of the five nonepidermotropic CTCL. Mig
expression co-localized with but was generally less pronounced than
IP-10 expression (Fig 1b). In the CD81 CTCL (no. 17) IP-10 and
Mig mRNA were expressed only focally, and co-localized with
infiltration of few CD41 reactive T cells, as assessed on serial sections.
In the dermal infiltrates variable expression of IP-10 and Mig mRNA
was observed in eight and twelve of 17 CTCL biopsies, respectively.
Focal expression of IL-8 mRNA was found in only two of 15
CTCL biopsies tested (nos 2 and 6), and was associated, in both cases,
with epidermal necrosis and accumulation of neutrophils.
In contrast, all four psoriatic skin lesions included as positive controls
showed abundant IL-8 mRNA expression in the upper layers of
the epidermis, which was generally associated with infiltration of
neutrophils. In normal skin of psoriatic patients and normal control
skin neither IP-10, nor Mig, nor IL-8 mRNA expression were
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Table I. Sequence and location of PCR primers
Primer Sequence Location on mRNAa
IP-10 sense 59-TGACTCTAAGTGGCATTCAAGG-39 nts 107–128
IP-10 anti-sense 59-GATTCAGACATCTCTTCTCACCC-39 nts 275–295
Mig sense 59- GTATCTGAGGCACATGTCAGG 39 nts 779–800
Mig anti-sense 59- AAAGGCACTGGATTGTGGTAGG 39 nts 1098–1120
IL-8 senseb 59AGTGCGTAATACGACTCACTATAGGGTCTGCAGCTCTGTGTGAAGG- 39 nts 136–155
IL-8 anti-sensec 59AGTGCGAATTAACCCTCACTAAAGGGCATCTTCACTGATTCTTGG- 39 nts 413–433
aAs described in Luster et al (1985) for IP-10, Farber (1993) for Mig, and Schmid and Weissman (1987) for IL-8.
bT7 RNA polymerase promotor sequence is underlined.
cT3 RNA polymerase promotor sequence is doubly underlined.
Table II. Relationship between IP-10, Mig, and IL-8 mRNA expression and epidermal infiltration by neoplastic T cells in 17
CTCL patients
Epidermotropismb RNA in situ hybridizationc
Diagnosisa Extent CD4 CD8 IP-10 mRNA Mig mRNA IL-8 mRNA
1. MF, patch 111 11 11 11 1 –
2. MF, plaque 111 111 occ 11 11 1d
3. MF, plaque 11 11 occ 1 1 –
4. MF, plaque 11 11 occ 11 – –
5. MF, plaque 11 11 11 11 1 –
6. MF, plaque 11 11 occ 1 1 1d
7. MF, plaque 1 1 occ 11 1 ND
8. MF, plaque 1 1 – – – –
9. MF, tumor 1 1 – 1 1 –
10. MF, tumor 1 1 – 1 – –
11. MF, tumor 1 1 occ 1 – –
12. MF, tumor – – – – – ND
13. CTCL, pleomorphic – – – – – –
14. CTCL, pleomorphic – – – – – –
15. CTCL, pleomorphic – – – – – –
16. CTCL, pleomorphic – – – – – –
17. CTCL, CD81 111 1F 111 1F 1F –
aMF, mycosis fungoides; CTCL, cutaneous T cell lymphoma; ND, not done; F, focal.
bScreening epidermotropism: 111, extensive; 11, moderate; 1, sparse; occ, occasional; –, absent.
cScoring RISH: 11, many foci; 1, few foci; –, negative.
dAssociated with epidermal necrosis and accumulation of neutrophils.
observed. Sense controls for IP-10 (Fig 1c), Mig, and IL-8 were
negative in all cases.
DISCUSSION
In this study, using RISH, we demonstrated a strong association
between epidermal IP-10 mRNA expression and the presence of
intraepidermal T cells. IP-10 mRNA expression was found in 11 of
12 epidermotropic CTCL, but not in any of the five nonepidermotropic
CTCL. IP-10 mRNA expression correlated with the epidermal infiltra-
tion of CD41 neoplastic T cells, rather than reactive CD81 T cells.
In accordance, in vitro studies have demonstrated chemoattractive
activity of IP-10 towards activated CD41 T cells but not towards
CD81 T cells (Taub et al, 1993b). Mig mRNA expression was found
in seven of the 12 epidermotropic CTCL, but not in the any of the
five nonepidermotropic CTCL. In the epidermis, Mig expression co-
localized with IP-10 expression, but was generally less pronounced.
The pattern of IP-10, as well as Mig mRNA expression in the
epidermis (see also Fig 1), suggests that these chemokines are produced
by keratinocytes, although we cannot exclude that intraepidermal
leukocytes may also contribute to the chemokine expression. The
production of IP-10 mRNA (Boorsma et al, 1994) and protein (Gottlieb
et al, 1988) by keratinocytes upon stimulation by IFN-γ has been well
established. Moreover, it has been shown that keratinocytes produce
much more IP-10 protein compared with endothelial cells, monocytes,
and fibroblasts after stimulation with equal amounts of INF-γ (Luster
and Ravetch, 1987).
The distribution of IP-10 and Mig mRNA expression was often
patchy, even in cases in which the epidermal CD41 T cells were
distributed more uniformly throughout the epidermis. This phenom-
enon might be due to a characteristic feature of chemokines in that
their expression is inducible and transient. In recent studies in allergic
contact dermatitis,1 a similar discrepancy between the localization of
IP-10 mRNA (patchy) and the localization of intraepidermal T cells
showing a more even distribution was observed. In cases without
epidermal infiltration by CD31CD41 T cells, however, epidermal IP-
10 mRNA expression was never found. The association between
epidermal IP-10 mRNA expression and the presence of CD41 T cells
both in CTCL and in allergic contact dermatitis suggests that IP-10
plays an important role in the preferential infiltration of both benign
and neoplastic CD41 cells in the epidermis.
This conclusion is consistent with the results of immunohistochemical
studies reported by Sarris et al (1995). Using a polyclonal antibody
against IP-10, these authors noted increased expression of IP-10
protein in the epidermis of epidermotropic CTCL; however, in
nonepidermotropic CTCL as well as in normal human skin, basal layer
keratinocytes consistently expressed IP-10 protein. In contrast, in our
study IP-10 mRNA was not observed in the epidermis of normal human
skin, or in nonepidermotropic CTCL. The constitutive expression of
IP-10 protein in the basal layers of normal epidermis, as found by
Sarris et al (1995), is unexplained.
Concerning Mig, our results suggest that epidermal expression of
this chemokine might also contribute to epidermal infiltration by
CD41 cells. Because previous in vitro and in vivo studies showed that
IFN-γ is the only inducer of Mig (Farber, 1997), our observations
1Flier J, van der Stoop PM, van Beek PJ: IP-10 mRNA is expressed in allergic
but not in irritant contact dermatitis. J Invest Dermatol 109:451, 1997 (abstr.)
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Figure 1. Abundant epidermal IP-10 and Mig mRNA expression in
early MF lesion. In situ hybridization with 35S-UTP-labeled IP-10 anti-sense
RNA (a), Mig anti-sense (b), and IP-10 sense RNA probe (c) followed by
emulsion autoradiography was performed on serial cryostat sections as described
in Materials and Methods. (a, b) Large foci of silver grains representing sites of
IP-10 and Mig mRNA transcripts in the epidermis. (c) Absence of silver grains
in the epidermis with sense probe showing the specificity of the in situ
hybridization procedure. Scale bar, 45 µm.
further indicate that INF-γ is an important inducer of chemokine
expression in epidermotropic CTCL.
Previous studies suggested that IL-8 is responsible for the infiltration
of T cells into the epidermis of CTCL (Hansen et al, 1991; McLean
Wismer et al, 1994). Using a polyclonal antibody against IL-8, Hansen
et al demonstrated elevated IL-8 immunoreactivity in the epidermis of
six CTCL patients, and suggested that IL-8, by its chemoattractive
properties, is responsible for the migration of T cells towards the
epidermis. More recently, McLean Wismer et al (1994), using the
monoclonal antibody 52E8, raised against IL-8 (Sticherling et al, 1989)
as well as RISH, reported intense epidermal expression of IL-8 mRNA
and protein in 14 of 15 CTCL lesions, compared with negligible
reactivity in normal human epidermis; however, a correlation between
IL-8 expression and epidermotropism was not made.
In contrast, in this study focal IL-8 mRNA expression was detected
in the epidermis of only two of 15 CTCL biopsies, which is consistent
with the observations of Volc-Platzer et al who could not detect IL-8
mRNA in a group of five epidermotropic T cell lymphoma.2 These
and other observations strongly argue against a role of IL-8 in epidermal
T cell infiltration in CTCL. First, in both CTCL cases demonstrating
epidermal IL-8 mRNA expression, this expression was associated
with epidermal necrosis and accumulation of CXCR1 expressing
neutrophils. Second, the reliability of our RISH procedures was
confirmed by demonstration of IL-8 mRNA in the upper layers of
the epidermis in four untreated psoriasis lesions. An identical expression
pattern has been reported previously (Gillitzer et al, 1991; Kulke et al,
1996). Third, using the monoclonal antibody 52E8 raised against IL-8
(kindly provided by Dr. M. Sticherling, Department of Dermatology,
University of Kiel, Kiel, Germany), which was also used in the study
of McLean Wismer et al (1994), we found no or minimal epidermal
staining in the epidermis of the epidermotropic CTCL. In contrast, a
uniform suprabasal epidermal staining was found in all five nonepiderm-
otropic CTCL as well as in normal skin (data not shown). Identical
results in normal skin have been reported by Sticherling et al (1991),
which have resulted in the view that antibody 52E8 may react with a
storage form of IL-8, but not with biologically active IL-8. Fourth, if
IL-8 plays a role in epidermotropism, one would expect that the
epidermotropic T cells express receptors for IL-8. Using monoclonal
antibodies against CXCR1 and CXCR2, however, intraepidermal and
dermal CD41 T cells were consistently negative for both receptor
antibodies. Previous studies using these antibodies against CXCR1 and
CXCR2, demonstrated expression of CXCR2 in upper keratinocytes
in lesional psoriatic skin (Beljaards et al, 1997; Bornscheuer et al, 1997).
The observation that the neoplastic CD41 T cells in these CTCL do
not stain with antibodies against CXCR1 and CXCR2 is consistent
with recent studies demonstrating that CXCR1 and CXCR2 are
expressed by only a small proportion of CD81 T cells, but not by
CD41 T cells (Chuntarapai et al, 1994; Qin et al, 1996), and underscore
recent doubt as to the chemoattractive activity of IL-8 towards CD41
T cells (Taub et al, 1993a; Carr et al, 1994; Roth et al, 1995).
In conclusion, the results of this study suggest that IP-10, and to a
lesser extent Mig, but not IL-8 is involved in the preferential infiltration
of neoplastic CD41 T cells in CTCL.
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